Objective: To observe the therapeutic effect of Chinese medicine on chronic disease in foreign country.
Methods: Forty-two cases of chronic headache were treated with acupuncture, Chinese massage and herbal medicine in Switzerland. The efficacy assessment was performed for the symptom score and the physical and mental improvements by the patients themselves before and after treatment.
Results: The total effective rate of symptom scores was 85.7% (36/42) and the total effective rate of the self-assessment was 88.1% (37/42).
Conclusion: Chinese medicine achieves a significant and sustainable efficacy on chronic headache, which is similar to the effect of western medication. The Swiss patients with chronic headache much prefer to Chinese medical therapy.
Download full-text PDF |
Source |
---|
Sociol Health Illn
February 2025
Tampere Centre for Science, Technology and Innovation Studies, Faculty of Social Sciences, Tampere University, Tampere, Finland.
Multimorbidity, meaning multiple long-term conditions impacting a person's health, has become a rising societal and public health issue. The article contributes to the sociological study of chronic illness and multimorbidity by analysing how the blurriness of illnesses and entanglement of symptoms in multimorbidity is experienced and negotiated by people with coexisting chronic conditions. Drawing on qualitative interviews with people who live with endometriosis, fibromyalgia or hormonal migraine in Finland, we show how people with multiple chronic conditions distinguish between evolving symptoms based on past embodied experiences to make decisions about how to best manage their health.
View Article and Find Full Text PDFObjective: This study aims to characterize concurrent nasal symptoms in a cohort of patients with non-rhinogenic headache (NRH) presenting to an otolaryngology clinic.
Study Design: A prospective cohort.
Setting: Single tertiary care institution.
Pain Manag
January 2025
Neurology Department, Centro Hospitalar Universitário de São João, Porto, Portugal.
Background: OnabotulinumtoxinA demonstrates effectiveness in chronic migraine prevention but is hindered by variable patient responses. This study aims to identify modifiable and non-modifiable risk factors influencing the response to onabotulinumtoxinA.
Methods: We conducted a retrospective cohort study at a tertiary hospital involving chronic migraine patients treated with onabotulinumtoxinA.
J Headache Pain
January 2025
Department of Neurology, University of Utah, 383 Colorow Drive, Salt Lake City, UT, 84108, USA.
A key unanswered question in migraine neurobiology concerns the mechanisms that make the brain of migraineurs susceptible to cortical spreading depression (CSD, a spreading depolarization that underlies migraine aura and may trigger the migraine pain mechanisms). Important insights into this question can be obtained by studying the mechanisms of facilitation of CSD initiation in genetic mouse models of the disease. These models, all generated from families with hereditary migraine, allow the investigation of the functional consequences of disease-causing mutations at the molecular, cellular, synaptic and neural circuit levels.
View Article and Find Full Text PDFPak J Med Sci
January 2025
Huma Shams, MBB Department of Obstetrics and Gynaecology, Medical Teaching Institute, Lady Reading Hospital, Peshawar, Pakistan.
Objective: To explore the radiological findings of neurological disorders in obstetrics patients, their obstetric and fetal outcome.
Method: The cross-sectional study was conducted at Lady Ready Hospital (LRH), Peshawar from June 2022 till March, 2023. Sixty two obstetric patients with neurological symptoms were included.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!